Jim Cramer's latest portfolio ranks Moderna Inc 6th, advising to focus on recession-proof stocks during Fed rate cuts. Moderna faces challenges with vaccine competition and public reluctance, projecting high revenue but with concerns. Insider Monkey suggests AI stocks offer better returns than Moderna.